Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [31] Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
    IA Crippa
    J Gleeson
    V Fontana
    J-L Vincent
    J Creteur
    FS Taccone
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [32] Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury
    Sergio Vesconi
    Dinna N Cruz
    Roberto Fumagalli
    Detlef Kindgen-Milles
    Gianpaola Monti
    Anibal Marinho
    Filippo Mariano
    Marco Formica
    Mariano Marchesi
    René Robert
    Sergio Livigni
    Claudio Ronco
    Critical Care, 13
  • [33] Outcome of patients with acute renal failure treated with intermittent or continuous renal replacement therapy depending on the initial diagnosis: a retrospective analysis
    TH Schroeder
    K Dinkelaker
    R Vonthein
    R Fretschner
    K Unertl
    M Hansen
    Critical Care, 6 (Suppl 1):
  • [34] A primer on continuous renal replacement therapy for critically ill patients
    Joy, MS
    Matzke, GR
    Armstrong, DK
    Marx, MA
    Zarowitz, BJ
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) : 362 - 375
  • [35] Acute renal replacement therapy in critically ill octogenarian or older patients: prognostic factors and renal outcomes
    Alícia Molina-Andújar
    Joaquim Casals
    Jimena Del Risco-Zevallos
    Evelyn Hermida
    Luis F. Quintana
    Miquel Blasco
    Gaston Piñeiro
    Esteban Poch
    Journal of Nephrology, 2021, 34 : 1531 - 1536
  • [36] Continuous renal replacement therapy in critically ill pediatric patients
    Zobel, G
    Ring, E
    Rodl, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : S28 - S34
  • [37] Renal replacement therapy for critically ill patients: an intermittent continuity
    Zaccaria Ricci
    Stefano Romagnoli
    Critical Care, 18
  • [38] Acute renal replacement therapy in critically ill octogenarian or older patients: prognostic factors and renal outcomes
    Molina-Andujar, Alicia
    Casals, Joaquim
    Del Risco-Zevallos, Jimena
    Hermida, Evelyn
    Quintana, Luis F.
    Blasco, Miquel
    Pineiro, Gaston
    Poch, Esteban
    JOURNAL OF NEPHROLOGY, 2021, 34 (05) : 1531 - 1536
  • [39] Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality
    Bagshaw, Sean M.
    Uchino, Shigehiko
    Kellum, John A.
    Morimatsu, Hiroshi
    Morgera, Stanislao
    Schetz, Miet
    Tan, Ian
    Bouman, Catherine
    Macedo, Etienne
    Gibney, Noel
    Tolwani, Ashita
    Oudemans-van Straaten, Heleen M.
    Ronco, Claudio
    Bellomo, Rinaldo
    JOURNAL OF CRITICAL CARE, 2013, 28 (06) : 1011 - 1018
  • [40] Ultrafiltration in Japanese critically ill patients with acute kidney injury on renal replacement therapy
    Koichi Kitamura
    Koichi Hayashi
    Shigeki Fujitani
    Raghavan Murugan
    Toshihiko Suzuki
    Journal of Intensive Care, 9